LOS ANGELES, April 19, 2026 /PRNewswire/ -- The Breakthrough Prize Foundation today announced the winners of the 2026 Breakthrough Prizes, honoring scientists whose discoveries are significantly ...

Blood-pressure reduction is the only proven treatment to prevent stroke. Whether a single pill that combines three antihypertensive drugs at low doses, in addition to standard antihypertensive ...

Learn how to prevent bindness by actively monitoring your vision and knowing how to spot the warning signs.

“I never sleep in my contact lenses unless the contact lenses have FDA approval for extended wear because of the risk of ...

ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly ...

Company entered into an asset purchase agreement with Johnson & Johnson (J&J) to acquire all interests in botaretigene sparoparvovec (bota-vec) for the treatment of X-linked retinitis pigmentosa (XLRP ...

As published in The Lancet and presented at AAN, NIMBLE trial met its primary and key secondary endpoints at week 24, demonstrating potential best-in-class efficacy and convenience in gMG ...

Rosa Rademakers and Bryan Traynor received this year’s Breakthrough Prize for identifying the most common genetic cause of ...

SYNGAP1 encephalopathy is a rare genetic disorder for which there is no treatment. It causes epilepsy, intellectual disability, psychomotor delay and, frequently, autism. It arises from mutations in ...

There may be some truth to the saying "the eyes are the window to the soul." Age-related changes are reflected in the retina, ...